A 2026 prospective study of 256 patients found that GLP-1 weight-loss medications don’t significantly increase retained stomach contents before endoscopy when patients stop the medication one week prior and follow a 24-hour clear liquid diet. Only 8% of GLP-1 users had retained stomach contents compared to 6% of controls (P = 0.55), with no aspiration events or serious complications in either group. According to Gram Research analysis, proper preparation instructions effectively eliminate any increased risk from these popular medications.
A new study of 256 patients examined whether popular weight-loss and diabetes medications called GLP-1 drugs cause food to stay in the stomach longer before surgery. According to Gram Research analysis, when patients stopped taking these medications one week before an endoscopy procedure and followed a clear liquid diet for 24 hours, the amount of retained stomach contents was nearly identical to patients not taking the drugs (8% versus 6%). The findings suggest that with proper preparation instructions, these medications don’t create the safety concerns doctors previously worried about.
Key Statistics
A 2026 prospective observational study of 256 patients found that 8% of those taking GLP-1 receptor agonists had retained stomach contents before endoscopy compared to 6% of controls, a difference that was not statistically significant (P = 0.55).
In the same 256-patient study, endoscopy physicians reported concern about significant gastric contents in 19% of GLP-1 medication users versus 7% of controls, despite similar objective measurements of retained stomach contents between groups.
The 2026 study of 256 endoscopy patients found zero aspiration events, procedure cancellations, or emergency conversions to general anesthesia in either the GLP-1 medication group or control group, indicating no serious safety complications.
When GLP-1 medication users stopped their medication one week before endoscopy and followed a 24-hour clear liquid diet, their rate of retained stomach contents (8%) was nearly identical to patients not taking GLP-1 drugs (6%) in a 256-patient 2026 study.
The Quick Take
- What they studied: Whether GLP-1 receptor agonist medications (like semaglutide used for weight loss and diabetes) cause food to remain in the stomach longer before medical procedures, which could increase the risk of food entering the lungs during anesthesia.
- Who participated: 256 patients scheduled for elective endoscopy procedures (camera examination of the stomach). The study compared patients taking GLP-1 medications with patients not taking them, using standard fasting guidelines.
- Key finding: Only 8% of patients on GLP-1 drugs had retained stomach contents compared to 6% in the control group—a difference that was not statistically significant (P = 0.55). When patients stopped the medication one week before and followed a 24-hour clear liquid diet, the risk was essentially the same.
- What it means for you: If you take GLP-1 medications and need surgery or endoscopy, you likely don’t need to worry about dangerous stomach buildup if you follow your doctor’s fasting instructions carefully. However, this is a small study, so discuss your specific situation with your healthcare provider.
The Research Details
Researchers conducted a prospective observational study, meaning they followed patients forward in time and observed what happened naturally rather than randomly assigning them to different treatments. They enrolled 256 patients scheduled for elective endoscopy (a procedure where doctors use a camera to look inside the stomach). The control group followed standard 8-hour fasting before the procedure. Patients taking GLP-1 medications were instructed to stop the medication one week before their procedure and follow a stricter 24-hour clear liquid diet. During the endoscopy, doctors measured how much food or liquid remained in the stomach using suction whenever possible and also recorded their subjective impressions of stomach contents.
Previous studies suggested GLP-1 medications might slow stomach emptying, potentially creating a safety risk during surgery when food could accidentally enter the lungs. This prospective study directly measured stomach contents during actual procedures rather than relying on indirect evidence, providing more reliable information about real-world risk. The study also tested whether specific preparation instructions (stopping the medication and following a stricter diet) could eliminate any potential risk.
This study has several strengths: it directly measured stomach contents rather than estimating them, it was prospective (reducing memory bias), and it used appropriate statistical tests. However, the study is relatively small (256 patients), making it harder to detect small differences between groups. The study was observational rather than randomized, meaning patients weren’t randomly assigned to take or not take the medication, which could introduce bias. The study also relied partly on subjective physician impressions rather than only objective measurements.
What the Results Show
The main finding was that there was no statistically significant difference in retained gastric contents between the two groups. In the GLP-1 medication group, 8% of patients had retained stomach contents, compared to 6% in the control group (P = 0.55). This means the difference could easily have occurred by chance. Importantly, no patients in either group experienced aspiration (food entering the lungs), procedure cancellation, or needed emergency conversion to general anesthesia. These safety outcomes were identical across both groups, suggesting that with proper preparation, GLP-1 medications don’t create the serious complications doctors were concerned about.
One interesting secondary finding was that endoscopy physicians reported higher concern about significant gastric contents in the GLP-1 group (19%) compared to controls (7%). This suggests doctors were more worried about stomach contents in GLP-1 patients even though the actual measured amounts were similar. This discrepancy may reflect physician bias or concern based on previous reports, rather than objective differences in stomach contents. The finding highlights the importance of objective measurement rather than relying solely on clinical impression.
Previous retrospective studies (looking backward at medical records) suggested GLP-1 medications might increase retained stomach contents after standard 8-hour fasting. This prospective study provides more direct evidence and suggests that with appropriate preparation—stopping the medication one week before and following a 24-hour clear liquid diet—the risk is not significantly elevated. The study essentially confirms that proper preparation instructions can mitigate any potential risk from these medications.
The study is relatively small with only 256 patients, which limits the ability to detect small but clinically important differences. The study was observational rather than randomized, so patients weren’t randomly assigned to medication groups, which could introduce bias. The study only included patients undergoing elective endoscopy, so results may not apply to other types of surgery or emergency procedures. The study relied partly on subjective physician impressions rather than only objective measurements. Finally, the study didn’t examine what happens if patients don’t follow the preparation instructions (continuing the medication and using standard 8-hour fasting), which was the original concern.
The Bottom Line
If you take GLP-1 medications and need elective endoscopy or surgery, discuss with your healthcare provider about stopping the medication 1-2 weeks before the procedure and following a clear liquid diet for 24 hours before the procedure. This preparation appears to eliminate any increased risk. Do not make changes to your medication schedule without explicit instructions from your doctor. For emergency procedures, inform your surgical team that you take GLP-1 medications so they can take appropriate precautions.
This research is most relevant for people taking GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide, dulaglutide) who need elective endoscopy or surgery. It’s also important for anesthesiologists, surgeons, and gastroenterologists who care for these patients. People not taking GLP-1 medications don’t need to change their preoperative preparation based on this study.
The benefits of proper preparation (stopping medication and fasting) would be immediate—the study measured stomach contents at the time of the procedure. You would not need to wait days or weeks to see the benefit of following these instructions.
Frequently Asked Questions
Do GLP-1 weight loss drugs cause food to stay in your stomach longer before surgery?
A 2026 study of 256 patients found no significant difference in retained stomach contents between GLP-1 users (8%) and non-users (6%) when proper preparation was followed. Stopping the medication one week before and fasting with clear liquids for 24 hours appears to eliminate any increased risk.
Can you take semaglutide or other GLP-1 medications before a procedure?
You should stop GLP-1 medications one week before elective endoscopy or surgery, according to this 2026 study. Always follow your doctor’s specific instructions, as timing may vary based on your procedure type and individual health factors.
What’s the risk of aspiration if you take GLP-1 drugs during surgery?
In a 256-patient 2026 study, zero aspiration events occurred in either GLP-1 users or non-users when proper fasting protocols were followed. With appropriate preparation, the aspiration risk appears equivalent between groups.
How long should you fast before endoscopy if you take GLP-1 medications?
According to a 2026 study, patients taking GLP-1 drugs should follow a 24-hour clear liquid diet before endoscopy (compared to standard 8-hour fasting for others) and stop their medication one week prior. Always confirm specific fasting instructions with your healthcare provider.
Is it safe to have surgery while taking GLP-1 receptor agonists?
A 2026 study of 256 endoscopy patients found no serious complications in GLP-1 users when they stopped medication one week before and followed proper fasting. Discuss your specific surgery type and timing with your surgical team to determine the best medication management plan.
Want to Apply This Research?
- If you take GLP-1 medications and have an upcoming procedure, use the app to set a reminder to stop your medication exactly 7 days before your scheduled endoscopy or surgery, and track your adherence to the 24-hour clear liquid diet in the day before your procedure.
- Create a pre-procedure checklist in the app: (1) Stop GLP-1 medication 7 days before procedure, (2) Switch to clear liquids only 24 hours before procedure, (3) Document what you consumed during the fasting period, (4) Note any questions for your doctor about medication timing.
- After your procedure, log the outcome in the app (whether retained stomach contents were found, any complications) to build a personal record. If you have multiple procedures over time, tracking this information helps you and your doctor optimize your preparation strategy and may contribute to broader understanding of GLP-1 medication management.
This research summary is for educational purposes only and should not replace professional medical advice. GLP-1 medications should never be stopped or started without explicit instructions from your healthcare provider. If you take GLP-1 drugs and need any surgical procedure or endoscopy, discuss your medication management plan with your doctor, anesthesiologist, and surgeon well in advance. This study is relatively small and observational; individual results may vary. Always follow your healthcare provider’s specific preoperative instructions, as they may differ from general guidelines based on your personal health situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.